InterMune, AbbVie Data Case Could Add Fuel To Wider European Disclosure Debates
Executive Summary
In an interim judgment, the General Court of the European Union has stopped Europe’s top drug regulator from releasing trial data on Esbriet and Humira until it makes a final decision on access to such documents.